Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

1,274 total articles

First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement

First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement

AnaptysBio announced that its upcoming spin-off, First Tracks Biotherapeutics, secured $145 million through a private placement, including $80 million from the sale of primary shares. The spin-off, expected to complete on April 20, 2026, will launch with approximately $180 million in cash and a two-year cash runway to support clinical development o…

21shares Announces Distributions on TETH and TSOL

21shares Announces Distributions on TETH and TSOL

21shares announced distributions to shareholders of proceeds from staking rewards earned by its Ethereum (TETH) and Solana (TSOL) ETFs. The distributions are scheduled for payment on March 31, 2026. The announcement outlines the associated risks of investing in these cryptocurrency exchange traded products, including volatility, liquidity constrain…

Iterum Therapeutics Announces Filing of Winding Up Petition

Iterum Therapeutics Announces Filing of Winding Up Petition

Iterum Therapeutics plc has filed a winding up petition in the Irish High Court, moving towards liquidation due to insufficient cash resources, inability to comply with Nasdaq listing requirements, lack of viable strategic alternatives, and ongoing financial pressures from operating costs including commercialization of ORLYNVAH™. The company antici…

Quantum Biopharma Provides Corporate Update

Quantum Biopharma Provides Corporate Update

Quantum BioPharma Ltd. granted 35,000 stock options to employees and consultants, exercisable at CA$6.50 for five years, as part of its ongoing efforts to incentivize staff amidst its development of innovative biopharmaceutical assets targeting neurodegenerative and metabolic disorders.

Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting

Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting

Palvella Therapeutics announced two poster presentations at the 2026 American Academy of Dermatology Annual Meeting highlighting advances in their rare skin disease pipeline. Key data include the innovative QTORIN™ rapamycin anhydrous gel formulation overcoming prior drug stability issues and positive Phase 3 results in microcystic lymphatic malfor…

XORTX Announces Results of  Annual and Special Meeting of Shareholders

XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Therapeutics Inc. announced the results of its annual and special shareholders meeting held on March 24, 2026. Key approvals included election of all five board nominees, appointment of auditors, re-approval of the stock option plan, and authorization of share consolidation. The company focuses on developing treatments for gout and progressiv…

STMicroelectronics Reports on Resolutions to be Proposed at the 2026 Annual General Meeting of Shareholders

STMicroelectronics Reports on Resolutions to be Proposed at the 2026 Annual General Meeting of Shareholders

STMicroelectronics has detailed the resolutions for its 2026 Annual General Meeting, including approval of the 2025 financial accounts, distribution of quarterly dividends, reappointment of board members, and authorizations for share repurchases and issuances. The company also highlighted its sustainability commitments and compliance with regulator…

Datacentrex Announces Pricing of $20.17 Million Confidentially Marketed Public Offering at $2.00 per Share

Datacentrex Announces Pricing of $20.17 Million Confidentially Marketed Public Offering at $2.00 per Share

Datacentrex, Inc., a digital infrastructure company operating Scrypt compute assets, has priced a confidentially marketed public offering of common stock and pre-funded warrants at $2.00 per share, expecting gross proceeds of approximately $20.17 million. The offering will close around March 30, 2026, with net proceeds intended for working capital …

YPF SA reports

YPF SA reports

YPF SA, Argentina's largest energy company, has filed its annual Form 20-F for the fiscal year ended December 31, 2025, with the US Securities and Exchange Commission, including audited financial statements. The report is accessible on YPF's official website and the SEC website. As a major producer of oil and natural gas in Argentina, with signific…

DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document

DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document

DBV Technologies, a late-stage biopharmaceutical company focused on food allergy treatments, announced the filing of its 2025 Annual Report on Form 10-K with the U.S. SEC and the Universal Registration Document with the French market authority. The filings include comprehensive financial data, corporate governance reports, share buy-back informatio…

Rumble Announces Chief Financial Officer Transition

Rumble Announces Chief Financial Officer Transition

Rumble Inc., a Nasdaq-listed technology platform company, announced the appointment of Mike Masci as its new Chief Financial Officer effective March 31, 2026. Masci brings extensive experience from Intel in AI, cloud infrastructure, and financial leadership, positioning Rumble for growth as it scales its platform and pursues AI infrastructure oppor…

Nortech Systems Reports Fourth Quarter Results

Nortech Systems Reports Fourth Quarter Results

Nortech Systems Incorporated reported a profitable fourth quarter for 2025, achieving net income of $0.9 million compared to a loss in the prior year quarter. The company saw increased net sales to $30.3 million and significant improvement in EBITDA, reflecting successful strategic restructuring and operational efficiencies. Nortech also secured $1…

Auburn National Bancorporation, Inc. Elects New Director

Auburn National Bancorporation, Inc. Elects New Director

Auburn National Bancorporation, Inc. has expanded its Board of Directors to include Jeff Evans, who brings over 30 years of experience in property management, construction, and real estate. Evans is also nominated for reelection at the upcoming Annual Meeting of Shareholders. The company and its subsidiary, AuburnBank, operate primarily in East Ala…

Fortuna files Form 40-F, Annual Report

Fortuna files Form 40-F, Annual Report

Fortuna Mining Corp., a Canadian precious metals mining company, has filed its annual report on Form 40-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The filing includes audited consolidated financial statements, management's discussion and analysis, and an annual information form. The company oper…

XORTX Announces Change of Effective Date of Share Consolidation

XORTX Announces Change of Effective Date of Share Consolidation

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company focused on therapies for gout and progressive kidney disease, announced a delay in the effective date of its 1-for-5 share consolidation from March 27, 2026, to April 6, 2026. The consolidation remains subject to necessary approvals from the TSX Venture Exchange and Nasdaq Stock …

Abundia Global Impact Group Sets Annual Meeting of Stockholders and Provides Update on Its Annual Filings

Abundia Global Impact Group Sets Annual Meeting of Stockholders and Provides Update on Its Annual Filings

Abundia Global Impact Group, Inc. announced its 2026 Annual Meeting of Stockholders to be held on May 14, 2026, and provided an update on its annual filings. The company disclosed that its audited financial statements for fiscal year 2025 included a going concern qualification from its independent auditor, highlighting uncertainties regarding its a…